| Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-13,602 | -12,977 | -18,726 | -28,078 | -27,703 | -14,397 | -2,096 |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||
Depreciation and amortization | ||||||
4,979 | 5,386 | 6,590 | 7,575 | 4,896 | 3,791 | 2,566 |
Bad debt expense | ||||||
195 | 568 | 509 | 80 | 47 | 46 | 60 |
Stock-based compensation | ||||||
12,275 | 6,077 | 5,467 | 6,460 | 2,746 | 521 | 219 |
Loss on asset impairment | ||||||
- | - | - | - | - | - | 0 |
Restricted stock non-cash compensation | ||||||
- | - | - | - | 18,683 | 9,327 | 877 |
Compensation related to puttable common stock | ||||||
- | - | - | 54 | 54 | 18 | 0 |
Acquisition related deferred compensation | ||||||
0 | 0 | 1,419 | 946 | 0 | 0 | - |
Changes in fair value of contingent consideration liability | ||||||
0 | 18 | 30 | -1,350 | -43 | 106 | 0 |
Accretion of debt discount | ||||||
35 | 37 | 62 | 56 | - | - | - |
Change in fair value of warrant liability | ||||||
- | - | - | - | 1,244 | 1,600 | 32 |
Non-cash interest expense related to debt | ||||||
- | - | - | - | - | 23 | 0 |
Amortization of debt financing costs and accretion of debt discount | ||||||
- | - | - | - | 43 | 0 | 0 |
Other | ||||||
- | - | - | - | 11 | 30 | - |
Changes in operating assets and liabilities: | ||||||
Accounts receivable and unbilled receivables | ||||||
577 | -1,615 | 1,213 | 1,658 | 4,798 | 1,004 | -1,559 |
Unbilled receivables | ||||||
- | - | - | - | - | -96 | -41 |
Prepaid expenses and other assets | ||||||
881 | -1,313 | 1,437 | 863 | 801 | 3,274 | 1,201 |
Accounts payable | ||||||
-193 | -166 | 1,284 | -316 | -182 | 431 | -497 |
Accrued expenses | ||||||
2,055 | -2,988 | 4,228 | -304 | 432 | 3,232 | 1,105 |
Payment for Contingent Consideration Liability, Operating Activities | ||||||
0 | 2,366 | 0 | 0 | - | - | - |
Other liabilities | ||||||
215 | -209 | -2,084 | -281 | -102 | -64 | 1,194 |
Deferred revenue | ||||||
-952 | 3,021 | 3,702 | 4,451 | -2,833 | 504 | 60 |
Net cash provided by (used in) operating activities | ||||||
3,548 | -669 | -165 | -13,229 | -8,303 | 989 | 3,922 |
Cash flows from investing activities: | ||||||
Capital expenditures | ||||||
219 | 257 | 231 | 1,385 | 723 | 327 | 1,511 |
Addition of capitalized software development costs | ||||||
3,214 | 1,458 | 2,286 | 1,926 | 1,970 | 2,409 | 3,272 |
Addition of intangible assets | ||||||
0 | 0 | 275 | 275 | 0 | 0 | - |
Acquisition, net of cash acquired | ||||||
- | - | - | 25,717 | 0 | 1,914 | 0 |
Cash paid for deposits | ||||||
-119 | -190 | -118 | -21 | 226 | -534 | 11 |
Decrease (increase) in restricted cash | ||||||
- | - | - | 112 | 56 | 0 | 0 |
Net cash used in investing activities | ||||||
-3,553 | -1,907 | -2,912 | -29,212 | -2,411 | -5,186 | -4,772 |
Cash flows from financing activities: | ||||||
Proceeds from revolving line of credit | ||||||
23,850 | 24,350 | 20,250 | 5,000 | 0 | 7,478 | 0 |
Payments on revolving line of credit | ||||||
23,850 | 24,350 | 19,250 | 0 | 6,978 | 500 | 0 |
Proceeds from term loan | ||||||
- | - | - | 20,000 | 0 | 0 | - |
Payments on term loan | ||||||
750 | 656 | 375 | 5,343 | 0 | 0 | - |
Debt financing costs | ||||||
70 | 35 | 0 | 188 | 0 | 51 | - |
Amortization of Financing Costs, Financing Activities | ||||||
- | - | - | - | - | - | 0 |
Repayments on capital lease obligations | ||||||
1,497 | 1,556 | 1,425 | 1,493 | 1,246 | 1,022 | 164 |
Proceeds from the exercise of stock options | ||||||
872 | 313 | 1,887 | 1,299 | 1,568 | 29 | 44 |
Taxes paid related to net share settlement | ||||||
- | - | - | 22 | 0 | 0 | - |
Payment for Contingent Consideration Liability, Financing Activities | ||||||
0 | 1,308 | 0 | 0 | - | - | - |
Proceeds from the exercise of common stock warrant | ||||||
- | - | - | - | 40 | 0 | 0 |
Payment of offering costs | ||||||
- | - | - | - | - | 478 | 0 |
Proceeds from initial public offering, net | ||||||
- | - | - | - | 53,558 | 0 | 0 |
Net cash used in financing activities | ||||||
-1,445 | -3,242 | 1,086 | 19,250 | 46,942 | 5,455 | -120 |
Effect of exchange rate on cash, cash equivalents and restricted cash | ||||||
-394 | -227 | -567 | -196 | -133 | -390 | -40 |
Net decrease in cash, cash equivalents and restricted cash | ||||||
-1,845 | -6,047 | -2,559 | -23,387 | 36,094 | 867 | -1,010 |
Supplemental disclosures of cash flow information: | ||||||
Accretion of Series E Preferred Stock | ||||||
- | - | - | - | 2,289 | 4,743 | 3,941 |
Dividends, Preferred Stock | ||||||
- | - | - | - | - | - | 536 |
Accretion of Series A, B, C, D and E issuance costs | ||||||
- | - | - | - | 91 | 105 | 94 |
Accretion of puttable common stock | ||||||
- | - | - | - | 35 | 0 | 0 |
Cash paid for interest | ||||||
1,236 | 938 | 790 | 858 | 275 | 145 | 23 |
Non-cash property and equipment acquired under finance lease | ||||||
1,145 | 1,936 | 834 | 1,545 | 1,618 | 3,532 | 707 |
Non-cash property and equipment purchases in accounts payable | ||||||
136 | 0 | 22 | 368 | 236 | 112 | 69 |
Non-cash deferred offering costs in accounts payable and accrued expenses | ||||||
- | - | - | - | - | 2,307 | 0 |
Non-cash conversion of Series A, B, C, D and E preferred stock | ||||||
- | - | - | - | 77,139 | 0 | 0 |
Non-cash acquisition contingent consideration | ||||||
- | - | - | 2,322 | 0 | 0 | - |